Composition

• Rabeprazole sodium: 20 mg.
• Excipients: S.Q. For one enteric-coated tablet.

Indications

Treatment of Erosive or Ulcerative Gastroesophageal Reflux Disease [ GERD ]:

Newprazol is indicated for short-term ( 4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD) for those patients who have not healed after 8 weeks of treatment an additional 8 week  course of Newprazol may be considered.

Maintenance of Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease [GERD]:

Newprazol is indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease [GERD Maintenance].

Healing of Duodenal  Ulcers:

Newprazol is indicated for short-term ( up to four weeks ) treatment in the healing and symptomatic relief of duodenal ulcers.Most patients heal within four weeks.

Treatment of Pathological Hypersecretory Conditions,  Including Zollinger-Ellison Syndrome:

Newprazol is indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

Dosage & Administration

Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease [GERD]:

The recommended adult oral dose is one Newprazol 20 delayed-release tablet to be taken once daily for four to eight weeks. For those patients who have not healed after 8 weeks of treatment, an additional 8- weeks course of Newprazol may be considered.

Maintenance of Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease [GERD Maintenance]:

The recommended adult oral dose is one Newprazol 20 mg delayed-release to be taken once daily.

Healing of Duodenal Ulcers:

The recommended adult oral dose is one Newprazol 20 mg delayed-release tablet to be taken once daily after the morning meal for a period up to four weeks. Most patients with duodenal ulcer heal within four weeks. A few patients may require additional therapy to achieve healing.